BWTS SeaCURE Gains USCG AMS Acceptance
Evoqua Water Technologies LLC says that its SeaCURE Ballast Water Treatment System (BWTS) has been granted AMS Acceptance in all salinities.
System highlights
- SeaCURE benefits ship owners by providing a solution that can operate in fresh, brackish and sea water in any trade lane worldwide
- Based on proven, widely deployed Chloropac marine growth prevention system (MGPS) technology
- SeaCURE will now enter USCG type approval process
Following a rigorous review process, the manufacturers say that SeaCURE has been accepted for use as an AMS by the USCG. AMS acceptance means that vessel owners and operators are now permitted to use the SeaCURE ballast water treatment system in U.S. waters.
SeaCURE has previously been type-approved by the International Maritime Organization (IMO) and BSH, the Federal Maritime and Hydrographic Agency of Germany (Bundesamt für Seeschifffahrt und Hydrographie). Evoqua also will apply for and undergo thorough testing required toward full USCG type approval. Currently, no ballast water treatment system has full USCG type approval.
SeaCURE is an efficient, reliable, low cost to operate ballast water management system based on proven, widely deployed Chloropac electrochlorination technology from Electrocatalytic, now an Evoqua brand.
SeaCURE eliminates the need for storing or handling chemicals onboard due to in-situ generation of sodium hypochlorite from the natural salinity in sea water. Sodium hypochlorite biocide generation in a side stream taken off the ballast water main minimizes footprint making it an ideal choice for retrofits. Patented intake filter technology injects biocide into ballast seawater before it reaches the large surface filter intakes to reduce the growth of marine organisms that can clog the filters.
“AMS acceptance of SeaCURE builds on the exceptional results gained during testing by the International Maritime Organization and BSH,” said SeaCURE Product Manager David Palmer. “With more than a half century experience of Electrocatalytic serving the marine industry and a growing list of regulators approving and accepting the operational results of SeaCURE technology, we are confident as we move forward with the USCG type approval process.”
www.evoqua.com